Guardant Health, Inc News Releases http://investors.guardanthealth.com/ Guardant Health, Inc News Releases en Guardant Health to Present at the William Blair 2019 Growth Stock Conference http://investors.guardanthealth.com/news-releases/news-release-details/guardant-health-present-william-blair-2019-growth-stock REDWOOD CITY, Calif. , May 29, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today announced the company will be Wed, 29 May 2019 16:05:00 -0400 Guardant Health, Inc News Releases 7011 Guardant Health Announces Pricing of Public Offering of Common Stock http://investors.guardanthealth.com/news-releases/news-release-details/guardant-health-announces-pricing-public-offering-common-stock REDWOOD CITY, Calif. , May 22, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, announced today the pricing of its Thu, 23 May 2019 00:01:00 -0400 Guardant Health, Inc News Releases 6991 Guardant Health, Inc. Announces Proposed Public Offering of Common Stock http://investors.guardanthealth.com/news-releases/news-release-details/guardant-health-inc-announces-proposed-public-offering-common REDWOOD CITY, Calif. , May 20, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, announced today that it has commenced an Mon, 20 May 2019 16:17:00 -0400 Guardant Health, Inc News Releases 6981 Guardant Health to Present Precision Oncology Data Across the Continuum of Care at the ASCO Annual Meeting http://investors.guardanthealth.com/news-releases/news-release-details/guardant-health-present-precision-oncology-data-across-continuum REDWOOD CITY, Calif. , May 15, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), along with researchers from leading academic institutions and pharmaceutical companies, will present 27 abstracts at the ASCO Annual Meeting detailing new insights into precision oncology generated from its Wed, 15 May 2019 21:52:00 -0400 Guardant Health, Inc News Releases 6966 Guardant Health Reports First Quarter 2019 Financial Results and Raises 2019 Revenue Guidance http://investors.guardanthealth.com/news-releases/news-release-details/guardant-health-reports-first-quarter-2019-financial-results-and Q1 2019 revenue increase of 120% over prior year period and a substantial increase in gross margin REDWOOD CITY, Calif. , May 09, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its Thu, 09 May 2019 16:03:00 -0400 Guardant Health, Inc News Releases 6936 Guardant Health to Present at the Bank of America Merrill Lynch 2019 Health Care Conference http://investors.guardanthealth.com/news-releases/news-release-details/guardant-health-present-bank-america-merrill-lynch-2019-health REDWOOD CITY, Calif. , May 03, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today announced the company will be Fri, 03 May 2019 16:05:00 -0400 Guardant Health, Inc News Releases 6916 Guardant Health to Report First Quarter 2019 Financial Results on May 9, 2019 http://investors.guardanthealth.com/news-releases/news-release-details/guardant-health-report-first-quarter-2019-financial-results-may REDWOOD CITY, Calif. , May 02, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the first quarter 2019 after market close on Thursday, May 9, 2019 . Company management will host a corresponding conference call beginning at 1:30 p.m. Thu, 02 May 2019 18:21:00 -0400 Guardant Health, Inc News Releases 6906 Guardant Health Appoints Dr. Bahija Jallal to its Board of Directors http://investors.guardanthealth.com/news-releases/news-release-details/guardant-health-appoints-dr-bahija-jallal-its-board-directors REDWOOD CITY, Calif. , April 23, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets, and advanced analytics, announce today that it has appointed Dr. Tue, 23 Apr 2019 08:30:00 -0400 Guardant Health, Inc News Releases 6851 NILE Study Results Demonstrating Guardant360’s High Concordance to Tissue Testing in Advanced NSCLC Published in Clinical Cancer Research http://investors.guardanthealth.com/news-releases/news-release-details/nile-study-results-demonstrating-guardant360s-high-concordance REDWOOD CITY, Calif. , April 15, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), announced that the positive results from the NILE study, a head-to-head comparison of the Guardant360® assay to standard-of-care tissue testing for the identification of guideline-recommended biomarkers in Mon, 15 Apr 2019 16:37:00 -0400 Guardant Health, Inc News Releases 6816 Guardant Health Announces Commercial Payer Progress with more than 150 Million Lives Covered for Guardant360 http://investors.guardanthealth.com/news-releases/news-release-details/guardant-health-announces-commercial-payer-progress-more-150 REDWOOD CITY, Calif. , April 09, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), announced that its market leading liquid biopsy, Guardant360®, will be a covered benefit for the members of the health plans associated with eviCore, a technology assessment company. Tue, 09 Apr 2019 17:24:00 -0400 Guardant Health, Inc News Releases 6811